Pure Global
NCT04302376

Thrombotic Complications After Central Venous Catheterization

Thrombotic Complications After Central Venous Catheterization: a Prospective Observational Study
VU University Medical Center·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Central Venous Catheter Thrombosis
Drug/Device/Intervention
Cather-related thrombosis ultrasonography
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
VU University Medical Center
Location
Amsterdam, Netherlands
Timeline & enrollment
Phase
N/A
Start date
Dec 01, 2019
End date
Jul 01, 2021
Enrollment
180 participants
Primary outcome

Incidence of catheter-related thrombosis

Summary

Rationale: Complications related to central venous catheterization are mechanical, infectious
 or thrombotic in origin. Potential complications of catheter-related thrombosis are not
 insubstantial and include pulmonary embolism, post-thrombotic syndrome or thrombophlebitis.
 Incidence of catheter-related thrombosis at the intensive care unit is unclear and treatment,
 especially of asymptomatic thrombosis, remains ambiguous. Therefore a study is warranted that
 evaluates the incidence of catheter-related thrombosis and investigates its potential
 consequences. We hypothesize that the incidence of catheter-related thrombosis is 5-15%.
 
 Objective: To assess the incidence of symptomatic and asymptomatic catheter-related
 thrombosis.

ICD-10 classifications
Other venous embolism and thrombosisEmbolism and thrombosis of other specified veinsEmbolism and thrombosis of unspecified veinNonpyogenic thrombosis of intracranial venous systemPerianal venous thrombosis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04302376
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04302376 through Pure Global AI's free database. This phase not specified trial is sponsored by VU University Medical Center and is currently Recruiting. The study focuses on Central Venous Catheter Thrombosis. Target enrollment is 180 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.